WO2003072767A3 - Regulation de la lipase humaine - Google Patents

Regulation de la lipase humaine Download PDF

Info

Publication number
WO2003072767A3
WO2003072767A3 PCT/EP2003/001940 EP0301940W WO03072767A3 WO 2003072767 A3 WO2003072767 A3 WO 2003072767A3 EP 0301940 W EP0301940 W EP 0301940W WO 03072767 A3 WO03072767 A3 WO 03072767A3
Authority
WO
WIPO (PCT)
Prior art keywords
human lipase
regulation
disorders
reagents
human
Prior art date
Application number
PCT/EP2003/001940
Other languages
English (en)
Other versions
WO2003072767A2 (fr
Inventor
Jiing-Ren Liou
Original Assignee
Bayer Healthcare Ag
Jiing-Ren Liou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag, Jiing-Ren Liou filed Critical Bayer Healthcare Ag
Priority to AU2003218668A priority Critical patent/AU2003218668A1/en
Publication of WO2003072767A2 publication Critical patent/WO2003072767A2/fr
Publication of WO2003072767A3 publication Critical patent/WO2003072767A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Selon l'invention, des réactifs qui régulent la lipase humaine et des réactifs qui se lient à des produits géniques de la lipase humaine peuvent jouer un rôle dans la prévention, l'amélioration ou la correction de dysfonctionnements ou de maladies comprenant notamment le cancer, le diabète, les troubles du système nerveux central, l'asthme, l'obésité, les troubles cardiovasculaires et les troubles urologiques.
PCT/EP2003/001940 2002-02-27 2003-02-26 Regulation de la lipase humaine WO2003072767A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003218668A AU2003218668A1 (en) 2002-02-27 2003-02-26 Regulation of human lipase

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US35963402P 2002-02-27 2002-02-27
US60/359,634 2002-02-27
US36310102P 2002-03-12 2002-03-12
US60/363,101 2002-03-12
US39913302P 2002-07-30 2002-07-30
US60/399,133 2002-07-30
US40336002P 2002-08-15 2002-08-15
US60/403,360 2002-08-15

Publications (2)

Publication Number Publication Date
WO2003072767A2 WO2003072767A2 (fr) 2003-09-04
WO2003072767A3 true WO2003072767A3 (fr) 2004-03-11

Family

ID=27767926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/001940 WO2003072767A2 (fr) 2002-02-27 2003-02-26 Regulation de la lipase humaine

Country Status (2)

Country Link
AU (1) AU2003218668A1 (fr)
WO (1) WO2003072767A2 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032885A2 (fr) * 1999-11-05 2001-05-10 Millennium Pharmaceuticals, Inc. 18892, nouvelle lipase humaine
WO2001057188A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001064907A2 (fr) * 2000-03-02 2001-09-07 Incyte Genomics, Inc. Enzymes metabolisant les lipides
WO2001098342A1 (fr) * 2000-06-22 2001-12-27 Smithkline Beecham Corporation Composes
WO2002002762A1 (fr) * 2000-07-03 2002-01-10 Mochida Pharmaceutical Co., Ltd. Nouvelle lipase
WO2002024898A2 (fr) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. Nouvelle lipase humaine 47647 et utilisations
WO2002031131A1 (fr) * 2000-10-11 2002-04-18 Mochida Pharmaceutical Co., Ltd. Nouvelle phospholipase a1 (pla1)
WO2002063005A2 (fr) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Molecules associees a des lipides

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032885A2 (fr) * 1999-11-05 2001-05-10 Millennium Pharmaceuticals, Inc. 18892, nouvelle lipase humaine
WO2001057188A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001064907A2 (fr) * 2000-03-02 2001-09-07 Incyte Genomics, Inc. Enzymes metabolisant les lipides
WO2001098342A1 (fr) * 2000-06-22 2001-12-27 Smithkline Beecham Corporation Composes
WO2002002762A1 (fr) * 2000-07-03 2002-01-10 Mochida Pharmaceutical Co., Ltd. Nouvelle lipase
EP1298205A1 (fr) * 2000-07-03 2003-04-02 Mochida Pharmaceutical Co., Ltd. Nouvelle lipase
WO2002024898A2 (fr) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. Nouvelle lipase humaine 47647 et utilisations
WO2002031131A1 (fr) * 2000-10-11 2002-04-18 Mochida Pharmaceutical Co., Ltd. Nouvelle phospholipase a1 (pla1)
EP1329501A1 (fr) * 2000-10-11 2003-07-23 Mochida Pharmaceutical Co., Ltd. Nouvelle phospholipase a1 (pla1)
WO2002063005A2 (fr) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Molecules associees a des lipides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GILLER T ET AL: "TWO NOVEL HUMAN PANCREATIC LIPASE RELATED PROTEINS HPLRP1 AND HPLRP2 DIFFERENCES IN COLIPASE DEPENDENCE AND IN LIPASE ACTIVITY", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 267, no. 23, 1992, pages 16509 - 16516, XP002251906, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2003218668A1 (en) 2003-09-09
AU2003218668A8 (en) 2003-09-09
WO2003072767A2 (fr) 2003-09-04

Similar Documents

Publication Publication Date Title
WO2002036754A3 (fr) Regulation de la lipase acide lysosomale humaine
WO2004031375A3 (fr) Regulation de la pde1c humaine
WO2003072767A3 (fr) Regulation de la lipase humaine
WO2001077149A3 (fr) Regulation d'une proteine gpcr type cyslt2 humaine
WO2002006453A3 (fr) Regulation de protease a serine humaine de type desc1
WO2003052088A3 (fr) Regulation de la sialyltransferase humaine
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002031162A3 (fr) Regulation de l'enzyme du type phospholipase a2 humaine
WO2002031160A3 (fr) Regulation de l'enzyme de type a2 phospholipase humaine
WO2002055710A3 (fr) Regulation de l'acide phosphatase pourpre humain
WO2002031161A3 (fr) Regulation de l'enzyme humaine de type phospholipase
WO2002099106A3 (fr) Regulation de gpcr de type secretine humaine
WO2002042435A3 (fr) Regulation de la tyrosine phosphatase humaine
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2003100087A3 (fr) Regulation de nouvelles hydroxylases d'asparagine- humaines
WO2002031125A3 (fr) Regulation de l'enzyme semblable a phospholipase a2 humaine
WO2002057461A3 (fr) Regulation de la metalloprotease a zinc de type adam-ts humaine
WO2002062975A3 (fr) Regulation de la proteine humaine du type elongase hselo1
WO2002036731A3 (fr) Lipase acide lysosomiale de l'homme
WO2002036613A3 (fr) Regulation de la proteine humaine de type 'patched'
WO2002020747A3 (fr) Regulation de l'enzyme humaine du type tyrosine phosphatase
WO2003018815A3 (fr) Regulation de la grk humaine
WO2002101043A3 (fr) Regulation du recepteur ta4 humain
WO2003000903A3 (fr) Regulation de serine/threonine proteine kinase humaine de type nek
WO2004031234A3 (fr) Regulation du recepteur humain de l'alpha-latrotoxine, independant du calcium

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP